Role of glycosaminoglycans in cellular communication

Accounts of Chemical Research

Volumn 37, Issue 7, 2004, Pages 431-438

  Linhardt, Robert J ^a   Toida, Toshihiko ^b  

^a Research Rensselaer Polytechnic Institute   (United States)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; APOENZYME; BLOOD CLOTTING FACTOR 10A; CHEMOKINE; CHONDROITIN SULFATE; COLLAGEN; COMPLEMENT; CYTOKINE; DECORIN; EPIMERASE; FIBRINOGEN; FIBRONECTIN; GLYCOSAMINOGLYCAN; GLYPICAN; GROWTH FACTOR; HEPARIN; HYALURONIC ACID; LAMININ; LOW MOLECULAR WEIGHT HEPARIN; POLYANION; PROTEIN; PROTHROMBIN; SERINE PROTEINASE; SULFOTRANSFERASE; SYNDECAN; TENASCIN; THROMBIN; THROMBOCYTE FACTOR 4; UNINDEXED DRUG; VITRONECTIN;

ARTICLE; BACTERIUM; BINDING SITE; CANCER; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; DIABETES MELLITUS; DRUG COST; EXTRACELLULAR MATRIX; HUMAN; IMMUNITY; INFLAMMATION; NONHUMAN; OBESITY; PARASITE; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRUS; WOUND HEALING;

ANIMALS; BACTERIAL PHYSIOLOGY; CARBOHYDRATE SEQUENCE; CELL ADHESION; CELL COMMUNICATION; CHEMOKINES; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; HUMANS; MALE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PARASITES; SIGNAL TRANSDUCTION; VIRAL PHYSIOLOGY;

EID: 3242702218     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar030138x     Document Type: Article

References (64)

1. Linhardt, R. J. Perspective: 2003 Claude S. Hudson Award Address in Carbohydrate Chemistry. Heparin: Structure and Activity. J. Med. Chem. 2003, 46, 2551-2554.
2. Kolset S. O.; Gallagher: J. T. Proteoglycans in Haemopoietic Cells. Biochim. Biophys. Acta 1990, 1032, 191-211.
3. Day, A. J., Prestwich, G. D. Hyaluronan-binding Proteins: Tying up the Giant. J. Biol. Chem. 2002, 277, 4585-4588.
4. Esko J. D.; Selleck, S. B. Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate. Annu. Rev. Biochem. 2002, 71, 435-471.
5. Habuchi, H.; Tanaka, M.; Habuchi, O.; Yoshida, K.; Suzuki, H.; Ban, K.; Kimata, K. The Occurrence of Three Isoforms of Heparan Sulfate 6-O-Sulfotransferase Having Different Specificities for Hexuronic Acid Adjacent to the Targeted N-Sulfoglucosamine. J. Biol. Chem. 2000, 275, 2859-2868.
6. Capila, I.; Linhardt, R. J. Heparin-Protein Interactions. Angew. Chem., Int. Ed. 2002, 41, 390-412.
7. Lee, Y. C.; Lee R. T. Carbohydrate-Protein Interactions: Basis of Glycobiology. Acc. Chem. Res. 1995, 28, 321-327.
8. Bourin, M.-C.; Lindahl, U. Glycosaminoglycans and the Regulation of Blood Coagulation. Biochem. J. 1993, 289, 313-330.
9. Edens, R. E.; Linhardt, R. J.; Weiler, J. M. Heparin Is Not Just an Anticoagulant Anymore: Six and One-Half Decades of Studies on the Ability of Heparin to Regulate Complement Activation. Complement Profiles 1993, 1, 96-120.
10. Marcum, J. A.; McKenney J. B.; Rosenberg, R. D. Acceleration of Thrombin-Antithrombin Complex Formation in Rat Hindquarters via Heparin Like Molecules Bound to the Endothelium. J. Clin. Invest. 1984, 74, 341-350.
11. Edens, R. E.; Linhardt, R. J.; Bell, C. S.; Weiler J. M. Heparin and Derivatized Heparin Inhibit Zymosan and Cobra Venom Factor Activation of Complement in Serum. Immunopharmacology 1994, 27, 145-153.
12. Sullivan, K. E. Complement Deficiency and Autoimmunity. Curr. Opin. Pediatr. 1998, 10, 600-606.
13. Nelson, R. M.; Venot, A.; Bevilacqua, M. P.; Linhardt, R. J.; Stamenkovic, I. Carbohydrate-Protein Interactions in Vascular Biology. Annu. Rev. Cell Dev. Biol. 1995, 11, 601-631.
14. Edens, R. E.; LeBrun, L. A.; Weiler, J. M.; Linhardt, R. J.; Kaul, P. R. Certain High Molecular Weight Heparin Chains Have Affinity for Vitronectin. Arch. Biochem. Biophys. 2001, 391, 278-285.
15. Onuffer J. J.; Horuk R. Chemokines, Chemokine Receptors and Small-Molecule Antagonists: Recent Developments. Trends Pharmacol. Sci. 2002, 23, 459-467.
16. Perretti, M.; Getting S. J. Migration of Specific Leukocyte Subsets in Response to Cytokine or Chemokine Application In Vivo. Methods Mol. Biol. 2003, 225, 139-146.
17. Peterson, F. C.; Elgin, E. S.; Nelson, T. J.; Zhang, F.; Hoeger, T. J.; Linhardt, R. J.; Volkman, B. F. A Glycosaminoglycan Recognition Element of Lymphotactin Essential for In Vivo Chemokine Activity. J. Biol. Chem. 2004, 279, 12598-12604.
18. Kilpeläinen, I.; Kaksonen, M.; Kinnunen, T.; Avikainen, H.; Linhardt, R. J.; Fath, M.; Raulo, E.; Rauvala, H. Heparin-Binding Growth-Associated Molecule Contains Two Heparin Binding β-Sheet Domains That Are Homologous to the Thrombospondin Type I Repeat J. Biol. Chem. 2000, 275, 13564-13570.
19. Wong, M. M.; Fish, E. N. Chemokines: Attractive Mediators of the Immune Response. Semin. Immunol. 2003, 15, 5-14.
20. Lander, A. D.; Nie, Q.; Wan, F. Y. Do Morphogen Gradients Arise by Diffusion? Dev. Cell 2002, 2, 785-796.
21. Bali, J. P.; Cousse, H.; Neuzil, E. Biochemical Basis of the Pharmacologic Action of Chondroitin Sulfates on the Osteoarticular System. Semin. Arthritis Rheum. 2001 31, 58-68.
22. Akiyama, H.; Sakai, S.; Linhardt, R. J.; Goda, Y.; Toida, T.; Maitani, T. Chondroitin Sulfate Structure Impacts its Immunological Effects on Murine Splenocytes Sensitized with Ovalbumin. Biochem. J., in press.
23. Saadi, S.; Wrenshall, L. E.; Platt J. L. Regional Manifestations and Control of the Immune System. FASEB J. 2002, 16, 849-56.
24. Ibrahimi, O. A.; Zhang, F.; Lang-Hrstka, S. C.; Mohammadi, M.; Linhardt, R. J. A Kinetic Model for FGF, FGFR, and Proteoglycan Signal Transduction Complex Assembly, Biochemistry 2004, 43, 4724-4730.
25. Schlessinger, J.; Plotnikov, A. N.; Ibrahimi, O. A.; Eliseenkova, A. V.; Yeh, B. K.; Yayon, A.; Linhardt, R. J.; Mohammadi, M. Crystal Structure of a Ternary FGF-FGFR-Heparin Complex Reveals a Dual Role for Heparin in FGFR Binding and Dimerization. Mol. Cell 2000, 6, 743-750.
26. Allen, B. L.; Rapraeger, A. C. Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J. Cell Biol. 2003, 163, 637-648.
27. O'Rourke, L.; Ladbury, J. E. Specificity is Complex and Time-Consuming: Mutual Exclusivity in Tyrosine Kinase-Mediated Signaling. Acc. Chem. Res. 2003, 36, 410-416.
28. Jeffers M.; LaRochelle, W. J.; Lichenstein, H. S. Fibroblast Growth Factors in Cancer: Therapeutic Possibilities. Expert Opin. Ther. Targets 2002, 6, 469-482.
29. Yeh, B. K.; Plotnikov, A. N.; Eliseenkova, A. V.; Green, D.; Pinnel, J.; Polat, T.; Gritli-Linde, A.; Linhardt, R. J.; Mohammadi, M. Structural Basis for the Therapeutic Activity of Sucrose Octasulfate (SOS). Mol. Cell. Biol. 2002, 22, 7184-7192.
30. Saunders, S.; Jalkanen, M.; O'Farrell, S.; Bernfield, M. Molecular Cloning Of Syndecan, an Integral Membrane Proteoglycan. J. Cell Biol. 1989, 108, 1547-1556.
31. Veugelers, M.; Cat, B. D.; Muyldermans, S. Y.; Reekmans, G.; Delande, N.; Frints, S.; Legius, E.; Fryns, J.-P.; Schrander-Stumpel, C.; Weidle, B.; Magdalena, N.; David, G. Mutational Analysis of the GPC3/GPC4 Glypican Gene Cluster on Xq26 in Patients with Simpson-Golabi-Behmel Syndrome: Identification of Loss-of-Function Mutations in the GPC3 Gene. Hum. Mol. Genet. 2000, 9, 1321-1328.
32. Reizes, O.; Lincecum, J.; Wang, Z.; Goldberger, O.; Huang, L.; Kaksonen, M.; Ahima, R.; Hinkes, M. T.; Barsh, G. S.; Rauvala, H.; Bernfield, M. Transgenic Expression Of Syndecan-1 Uncovers A Physiological Control Of Feeding Behavior By Syndecan-3. Cell 2001, 106, 105-116.
33. Mizuguchi, S.; Uyama, T.; Kitagawa, H.; Nomura, K. H.; Dejima, K.; Gengyo-Ando, K.; Mitani, S.; Sugahara K.; Nomura, K. Chondroitin Proteoglycans are Involved in Cell Division of Caenorhabditis Elegans. Nature 2003, 423, 443-448.
34. Ringvall, M.; Ledin, J.; Holmborn, K.; van Kuppevelt, T.; Ellin, F.; Eriksson, I.; Olofsson, A. M.; Kjellen, L.; Forsberg, E. Defective Heparan Sulfate Biosynthesis and Neonatal Lethality in Mice Lacking N-Deacetylase/N- Sulfotransferase-1." J. Biol. Chem. 2000, 275, 25926-25930.
35. Grobe, K.; Ledin, J.; Ringvall, M.; Holmborn, K.; Forsberg, E.; Esko, J. D.; Kjellen L. Heparan Sulfate and Development: Differential Roles of the N-Acetylglucosamine N-Deacetylase/N-Sulfotransferase Isozymes. Biochim. Biophys. Acta 2002, 1573, 209-215.
36. Gallagher, J. T.; Hampson, I. N. Proteoglycans in Cellular Differentiation and Neoplasia. Biochem. Soc. Trans. 1984, 12, 541-543.
37. Vlodavsky, I.; Goldshmidt, O.; Zcharia, E.; Atzmon, R.; Rangini-Guatta, Z.; Elkin, M.; Peretz, T.; Friedmann, Y. Mammalian Heparanase: Involvement in Cancer Metastasis, Angiogenesis and Normal Development. Semin. Cancer Biol. 2002, 12, 121-129.
38. Arya, M.; Patel, H. R.; Williamson, M. Chemokines: Key Players in Cancer. Curr. Med. Res. Opin. 2003, 19, 557-564.
39. Filmus, J. Glypicans in Growth Control and Cancer. Glycobiology 2001, 11, 19R-23R.
40. Smetsers, T. F.; van de Westerlo, E. M.; ten Dam, G. B.; Clarijs, R.; Versteeg, E. M.; van Geloof, W. L.; Veerkamp, J. H.; van Muijen, G. N.; van Kuppevelt, T. H. Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma. Cancer Res. 2003, 63, 2965-2970.
41. Horton, M. R.; Boodoo, S.; Powell J. D. NF-Kappa B Activation Mediates the Cross-Talk Between Extracellular Matrix and Interferon-Gamma (IFN-Gamma) Leading to Enhanced Monokine Induced by IFN-Gamma (MIG) Expression in Macrophages. J. Biol. Chem. 2002 277, 43757-43762.
42. Marchetti, D.; Reiland, J.; Erwin, B.; Roy, M. Inhibition of Heparanase Activity and Heparanase-Induced Angiogenesis by Suramin Analogues. Int. J. Cancer 2003, 104, 167-174.
43. Folkman, J.; Langer, R.; Linhardt, R. J.; Haudenschild, C.; Taylor, S. Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone. Science 1983, 221, 719-725.
44. Lee, Y. S.; Shin, K. H.; Oh, D. K.; Linhardt, R. J.; Kim, Y. S. Suppression of Tumor Growth by a New Glycosaminoglycan Isolated from African Giant Snail Achatina fulica. Eur. J. Pharmacol. 2003, 465, 191-198.
45. Zacharski, L. R.; Loynes, J. T. The Heparins and Cancer. Curr. Opin. Pulm. Med. 2002, 8, 379-382.
46. Borsig, L.; Wong, R.; Feramisco, J.; Nadeau, D. R.; Varki, N. M.; Varki, A.; Heparin and Cancer Revisited: Mechanistic Connections Involving Platelets, P.-Selectin, Carcinoma Mucins, and Tumor Metastasis. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 3352-3357.
47. Neal, M. S. Angiogenesis: Is it the Key to Controlling the Healing Process? J. Wound Care 2001, 10, 281-287.
48. Mack, J. A.; Abramson, S. R.; Ben, Y.; Coffin, J. C.; Rothrock, J. K.; Maytin, E. V.; Hascall, V. C.; Largman, C.; Stelnicki, E. J. Hoxb13 Knockout Adult Skin Exhibits High Levels of Hyaluronan and Enhanced Wound Healing. FASEB J. 2003, 17, 1352-1354.
49. Gagneux, P.; Varki, A. Evolutionary Considerations in Relating Oligosaccharide Diversity to Biological Function. Glycobiology 1999, 9, 747-755.
50. Sawitzky, D. Protein-Glycosaminoglycan Interactions: Infectiological Aspects. Med. Microbiol. Immunol. 1996, 184, 155-161.
51. Liston, A.; McColl, S. Subversion of the Chemokine World by Microbial Pathogens. Bioessays 2003, 25, 478-488.
52. Rider, C. C. The Potential for Heparin and its Derivatives in the Therapy and Prevention Of HIV-1 Infection. Glycoconjugate J. 1997, 14, 639-642.
53. Campadelli-Fiume, G.; Cocchi, F.; Menotti, L.; Lopez, M. The Novel Receptors that Mediate the Entry of Herpes Simplex Viruses and Animal Alphaherpesviruses into Cells. Rev. Med. Virol. 2000, 10, 305-319.
54. Hileman, R. E.; Fromm, J. R.; Weiler, J. M.; Linhardt, R. J. Glycosaminoglycan-Protein Interactions: Definition of Consensus Sites in Glycosaminoglycan Binding Proteins. Bioessays 1998, 20, 156-167.
55. Chen, Y.; Maguire, T.; Hileman, R. E.; Fromm, J. R.; Esko, J. D.; Linhardt, R. J.; Marks, R. M. Dengue Virus Infectivity Depends on Envelope Protein Binding to Target Cell Heparan Sulfate. Nat. Med. 1997, 3, 866-871.
56. Barth, H.; Schäfer, C.; Adah, M. I.; Zhang, F.; Linhardt, R. J.; Toyoda, H.; Kinoshita-Toyoda, A.; Toida, T.; van Kuppevelt, T. H.; Depla, E.; von Weizsäcker, F.; Blum, H. E.; Baumert, T. F. Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate. J. Biol. Chem. 2003, 278, 41003-41012.
57. Marks, R. M.; Lu, H.; Sundaresan, R.; Toida, T.; Suzuki, A.; Imanari, T.; Hernaiz, M. J.; Linhardt, R. J. Probing the Interaction of Dengue Virus Envelope Protein with Heparin: Assessment of Glycosaminoglycan-Derived Inhibitors. J. Med. Chem. 2001, 44, 2178-2187.
58. Shukla, D.; Liu, J.; Blaiklock, P.; Shworak, N. W.; Bai, X.; Esko, J. D.; Cohen, G. H.; Eisenberg, R. J.; Rosenberg, R. D.; Spear P. G. A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry. Cell 1999, 99, 13-22.
59. Frick, I. M.; Schmidtchen, A.; Sjobring, U. Interactions Between M Proteins of Streptococcus pyogenes and Glycosaminoglycans Promote Bacterial Adhesion to Host Cells. Eur. J. Biochem. 2003, 270, 2303-2311.
60. Alvarez-Dominguez, C.; Vazquez-Boland, J. A.; Carrasco-Marin, E.; Lopez-Mato, P.; Leyva-Cobian, F. Host Cell Heparan Sulfate Proteoglycans Mediate Attachment and Entry of Listeria monocytogenes, and the Listerial Surface Protein Acta is Involved in Heparan Sulfate Receptor Recognition. Infect. Immun. 1997, 65, 78-88.
61. Freissler, E.; Meyer auf der Heyde, A.; David, G.; Meyer, T. F.; Dehio, C. Syndecan-1 and Syndecan-4 Can Mediate the Invasion of OpaHSPG-Expressing Neisseria gonorrhoeae into Epithelial Cells. Cell Microbiol. 2000, 2, 69-82.
62. Rathore, D.; McCutchan, T. F.; Hernaiz, M. J.; LeBrun, L. A.; Lang, S. C.; Linhardt, R. J. Direct Measurement of the Interaction of Glycosaminoglycans and a Heparin Decasaccharide with Malaria Circumsporozoite Protein. Biochemistry 2001, 40, 11518-11524.
63. Dong, J.; Peters-Libeu, C. A.; Weisgraber, K. H.; Segelke, B. W.; Rupp, B.; Capila, I.; Hernaiz, M. J.; LeBrun, L. A.; Linhardt, R. J. Interaction of the N-Terminal Domain of Apolipoprotein E4 with Heparin. Biochemistry 2001, 40, 2826-2834.
64. Rathore, D.; Hrstka, S. C. L.; Sacci, J. B.; de la Vega, P.; Linhardt, R. J.; Kumar, S.; McCutchan, T. F. Molecular Mechanism of Host Specificity in Plasmodium falciparum Infection: Role of Circumsporozoite Protein. J. Biol. Chem. 2003, 278, 40905-40910.